Ex) Article Title, Author, Keywords
Ex) Article Title, Author, Keywords
Ann Liver Transplant 2024; 4(2): 39-39
Published online November 30, 2024 https://doi.org/10.52604/alt.24.0020
Copyright © The Korean Liver Transplantation Society.
Correspondence to:Seok-Hwan Kim
Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea
E-mail: kjxh7@cnuh.co.kr
https://orcid.org/0000-0003-0209-0444
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
See original paper on 86
This manuscript discusses the safety and feasibility of donor right liver resection (DRLR) in individuals with a body mass index (BMI) of 30 kg/m2 or higher in the context of living donor liver transplantation (LDLT) [1]. With the global rise in obesity, there is an increasing number of potential liver donors with higher BMIs. However, the effect of donor obesity on both donor safety and recipient outcomes has not been extensively studied. Using data from a high-volume center in Asia, this study provides valuable evidence by comparing obese and normal-weight donors, focusing on key perioperative outcomes.
The authors should be commended for their rigorous methodology, including the use of matching to minimize bias. Their findings reveal no significant differences in major postoperative complications, length of hospital stay, or readmission rates between obese and normal-weight donors. This suggests that with appropriate donor selection and thorough preoperative evaluation, DRLR can be safely performed in selected high-BMI donors, potentially expanding the donor pool in a time of critical organ shortages globally.
However, it is important to note the study’s limitations, including its retrospective nature and the relatively small sample size after matching. Moreover, while the findings suggest that obese donors can be safely incorporated into LDLT programs, the study highlights the importance of strict preoperative assessments, particularly regarding liver steatosis and metabolic health, to manage the technical challenges posed by obesity. Future research, especially prospective and multi-center studies, will be essential in solidifying these results and helping to establish more comprehensive guidelines for the inclusion of obese donors in LDLT.
The author has no conflicts of interest to declare.
Ann Liver Transplant 2024; 4(2): 39-39
Published online November 30, 2024 https://doi.org/10.52604/alt.24.0020
Copyright © The Korean Liver Transplantation Society.
Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea
Correspondence to:Seok-Hwan Kim
Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea
E-mail: kjxh7@cnuh.co.kr
https://orcid.org/0000-0003-0209-0444
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
See original paper on 86
This manuscript discusses the safety and feasibility of donor right liver resection (DRLR) in individuals with a body mass index (BMI) of 30 kg/m2 or higher in the context of living donor liver transplantation (LDLT) [1]. With the global rise in obesity, there is an increasing number of potential liver donors with higher BMIs. However, the effect of donor obesity on both donor safety and recipient outcomes has not been extensively studied. Using data from a high-volume center in Asia, this study provides valuable evidence by comparing obese and normal-weight donors, focusing on key perioperative outcomes.
The authors should be commended for their rigorous methodology, including the use of matching to minimize bias. Their findings reveal no significant differences in major postoperative complications, length of hospital stay, or readmission rates between obese and normal-weight donors. This suggests that with appropriate donor selection and thorough preoperative evaluation, DRLR can be safely performed in selected high-BMI donors, potentially expanding the donor pool in a time of critical organ shortages globally.
However, it is important to note the study’s limitations, including its retrospective nature and the relatively small sample size after matching. Moreover, while the findings suggest that obese donors can be safely incorporated into LDLT programs, the study highlights the importance of strict preoperative assessments, particularly regarding liver steatosis and metabolic health, to manage the technical challenges posed by obesity. Future research, especially prospective and multi-center studies, will be essential in solidifying these results and helping to establish more comprehensive guidelines for the inclusion of obese donors in LDLT.
The author has no conflicts of interest to declare.